Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Fusidinsäure, ATC D06AX01

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jan 03, 2028 · 493 days left·Open·Supplies·Framework
Sign up to saveOpen documents
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Fusidinsäure, ATC D06AX01

40/100

Opportunity Score

High riskLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

The open-house model does not guarantee any volume or revenue; actual business depends on pricing and market dynamics.

If a competitive discount agreement for Fusidic acid is concluded by AOK Bayern or other insurers, the open-house agree...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Weak opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Feb 2028
  • Non-exclusive discount agreements for pharmaceutical product Fusidic acid (ATC D06AX01) for the region of Bavaria (DE212).
Show full summary

Non-exclusive open-house discount agreements for Fusidic acid (ATC D06AX01) by AOK Bayern. All qualified pharmaceutical companies can join identical, non-negotiable contracts from March 2026 to February 2028. No selection, no estimated value.

Risks

The open-house model does not guarantee any volume or revenue; actual business depends on pricing and market dynamics.

If a competitive discount agreement for Fusidic acid is concluded by AOK Bayern or other insurers, the open-house agree...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical company (pharmazeutisches Unternehmen).

Administrative

  • Submit signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Submit signed contract and annex (Festlegung der vertragsgegenständlichen Arzneimittel).

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Fusidinsäure, ATC D06AX01

Non-exclusive discount agreements for Fusidic acid (ATC D06AX01) under an open-house model. Contracts are open to all qualified pharmaceutical companies.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Feb 2026 - Feb 2028

Category

Pharmaceutical products

Procurement Details

Publication date
13 Jan 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
23365-2026

Documents (2)

Procurement document 1Submission portal 1

Similar tenders

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30